Subscribe To
Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases
Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th...
November 1, 2023, 11:31 pm
Zyversa therapeutics announces publication in molecular neurobiology reinforcing data demonstrating that inflammasome asc inhibitor ic 100 attenuates the inflammatory response causing neuronal damage
Molecular Neurobiology publication demonstrated that NLRP3 inflammasomes have an important role in the pathogenesis of multiple sclerosis (“MS”) b...
November 1, 2023, 12:07 pm
Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller
Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and protein levels, and ...
October 31, 2023, 11:00 am
Phio jumps 91% on encouraging preclinical cancer drug data
Data from preclinical studies show that Phio's (PHIO) cancer drug PH-894 is effective in BRD4 inhibition...
October 12, 2023, 12:47 pm
Zyversa therapeutics announces research published in frontiers in immunology reinforcing ic 100’s rationale for inhibiting multiple inflammasomes to control inflammation in various inflammatory diseas
Activation of multiple inflammasome pathways contributes to pathological inflammation in neurodegenerative (“CNS”) diseases, such as amyotrophic l...
September 12, 2023, 10:30 am
Praxis precision medicines to present analyses of patient-focused, clinically meaningful endpoints from essential1 study of ulixacaltamide in essential tremor at the 2023 mds international congress
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...
August 28, 2023, 7:00 am
Atossa therapeutics is targeting multiple stages of the breast cancer continuum with oral endoxifen
Atossa Therapeutics Inc (NASDAQ:ATOS) is targeting three different stages of the breast cancer continuum with its proprietary oral form of Endoxifen, ...
August 23, 2023, 1:16 pm
Panbela announces poster presentation at the endocrine society meeting: polyamine inhibition and β-cell preservation in recent onset type 1 diabetes
MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disru...
June 26, 2023, 12:15 pm
Allakos presents preclinical data at eaaci hybrid congress 2023 highlighting lirentelimab and ak006 mechanisms of mast cell inhibition
– AK006 inhibits IgE mediated mast cell activation and shows similar IgE inhibitory activity as remibrutinib –– AK006 also inhibits non-IgE mast...
June 12, 2023, 11:02 am
Allakos announces upcoming presentation on lirentelimab and ak006 mast cell inhibition at the european academy of allergy and clinical immunology (eaaci) hybrid congress 2023
SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics whi...
June 5, 2023, 11:02 am
Praxis precision medicines to present at the 2023 jefferies healthcare conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...
June 2, 2023, 9:00 am
Zyversa therapeutics reports first quarter 2023 corporate and financial results
Key Highlights: Continued progress has been made in advancing an investigator-initiated clinical trial to gain human proof-of-concept for Cholesterol ...
May 12, 2023, 1:07 pm
Salarius pharmaceuticals announces $6 million private placement priced at-the-market under nasdaq rules
HOUSTON, May 12, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein
May 12, 2023, 12:00 pm
Can-fite biopharma spikes on pancreatic cancer inhibition finding
Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, infl...
May 2, 2023, 1:12 pm
Rumi scientific announces data demonstrating disease modifying effect of brd9 inhibition in a huntington’s disease animal model
Data presented at the CHDI Foundation 18th Annual Huntington’s Disease Therapeutics Conference NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) — Rumi Sc...
April 26, 2023, 11:05 am
Panavance therapeutics announces positive preclinical data demonstrating gp-2250 single-agent and combination activity for the treatment of ovarian cancer
Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2023 GP-2250’s antineoplastic effects on ovarian cancer cells i...
April 17, 2023, 12:05 pm
Salarius pharmaceuticals to present at the diamond equity research emerging growth invitational conference
HOUSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein
April 4, 2023, 4:02 pm
Immuneering presents preclinical data with lead program imm-1-104 supporting universal-ras activity
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS...
March 5, 2023, 11:30 pm
Cidara to present at esmo targeted anticancer therapies congress
SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics des...
February 28, 2023, 8:00 am
Cardiff oncology to present at the cowen 43rd annual health care conference
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 ...
February 27, 2023, 8:15 am
